Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 28813164

Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Dec 1
First author
Ott PA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Dec 1;35(34):3794-3795. doi: 10.1200/JCO.2017.74.5141.
    note
    Source null
    related pmid
    29016228
    relationship
    Comment in
  2. citation
    Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S47-S50. doi: 10.21037/tlcr.2017.10.12.
    note
    Source null
    related pmid
    29299410
    relationship
    Comment in
  3. citation
    Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S67-S70. doi: 10.21037/tlcr.2017.10.06.
    note
    Source null
    related pmid
    29299415
    relationship
    Comment in
  4. citation
    Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S78-S83. doi: 10.21037/tlcr.2017.10.04.
    note
    Source null
    related pmid
    29299418
    relationship
    Comment in
  5. citation
    Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S84-S87. doi: 10.21037/tlcr.2017.10.02.
    note
    Source null
    related pmid
    29299419
    relationship
    Comment in

Authors and identifiers

  1. name
    Ott PA
    type
    Author
  2. name
    Elez E
    type
    Author
  3. name
    Hiret S
    type
    Author
  4. name
    Kim DW
    type
    Author
  5. name
    Morosky A
    type
    Author
  6. name
    Saraf S
    type
    Author
  7. name
    Piperdi B
    type
    Author
  8. name
    Mehnert JM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ott PA
    type
    Author
  2. name
    Elez E
    type
    Author
  3. name
    Hiret S
    type
    Author
  4. name
    Kim DW
    type
    Author
  5. name
    Morosky A
    type
    Author
  6. name
    Saraf S
    type
    Author
  7. name
    Piperdi B
    type
    Author
  8. name
    Mehnert JM
    type
    Author
bibliography ids
  1. nci-bib-0ad2d05c64e8009a807ceda0
book metadata
content sha256
9cfd1268037accc179cc129c767961cb190f147760496c238f25819381ab4915
document type
citation
dois
  1. 10.1200/JCO.2017.72.5069
electronic publication date
display
2017 Aug 16
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28813164
immutable id
pubmed:28813164@9cfd1268037accc179cc129c767961cb190f147760496c238f25819381ab4915
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
34
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3823-3829
volume
35
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Dec 1;35(34):3794-3795. doi: 10.1200/JCO.2017.74.5141.
    note
    Source null
    related pmid
    29016228
    relationship
    Comment in
  2. citation
    Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S47-S50. doi: 10.21037/tlcr.2017.10.12.
    note
    Source null
    related pmid
    29299410
    relationship
    Comment in
  3. citation
    Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S67-S70. doi: 10.21037/tlcr.2017.10.06.
    note
    Source null
    related pmid
    29299415
    relationship
    Comment in
  4. citation
    Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S78-S83. doi: 10.21037/tlcr.2017.10.04.
    note
    Source null
    related pmid
    29299418
    relationship
    Comment in
  5. citation
    Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S84-S87. doi: 10.21037/tlcr.2017.10.02.
    note
    Source null
    related pmid
    29299419
    relationship
    Comment in
outcomes validated
false
pmid
28813164
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
fbaaa0be811eb13b21a6bf4f03e255b39abf2cf1451bb5530f5a7d1d2da48e3c
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Dec 1
precision
day
year
2017
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28813164/
title
Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study.

Preserved source evidence · Independent clinical review pending · Not medical advice